US 12,486,222 B2Granted

Compounds as soluble epoxide hydrolase inhibitors

AssigneeUniversitat De Barcelona

InventorsSandra Codony I Gisbert, Cristian Gaspar Griñan Ferre, Mercè Pallàs Lliberia, Santiago Vázquez Cruz, Yumin Oh

Life of this patent

Estimating the term…

Abstract

The present invention relates to soluble epoxide hydrolase (sEH) inhibitors of formula (I) to processes for their obtention and to their therapeutic indications.

Claims2

Dependent claims

A compound having the following structure:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 18/915,070Filed 14 Oct 2024 · continuation
Priority: EP 2138223724 Mar 2021
Published: US 2025/0115548 A110 Apr 2025
Granted: 2 Dec 2025
Term ends: Not estimatedThe source records don’t support an estimate.

Classification20 codes

C07C 275/26
Derivatives of urea, i.e. compounds containing any of the groups [IMAGE cpc-sch-C07C-0967.gif], the nitrogen atoms not being part of nitro or…:…
A61K 31/17
Amides, e.g. hydroxamic acids: having the group >N—C—N< or >N—C—N<, e.g. urea, thiourea, carmustine
A61K 31/445
Non condensed pyridines; Hydrogenated derivatives thereof: non condensed piperidines, e.g. piperocaine
A61K 31/453
Containing further heterocyclic ring systems: containing a six-membered ring with oxygen as a ring hetero atom

Family

PCT/EP2022/056557Parent of this continuation · filed 14 Mar 2022
US 2025/0115548 A1Pre-grant publication · published 10 Apr 2025
Application18/552,146Parent of this continuation
US 2024/0182406 A1Published application
US 12,486,222 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results